Skip to main content

Gouk Warren's Form 4/A amendment

Amended

LifeStance Health Group, Inc.LFST · filed Jun 22, 2022

Accession no.
0000899243-22-023602
Filed
Jun 22, 2022
Trade date
Jun 9, 2022
Filing delay
13 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Jun 17, 2022

This filing lists 1 non-derivative transaction. It carries over 1 transaction from the original filing that it did not restate. Open-market sales total $432.2K. It was filed 13 days after the trade.

This amendment restates part of 0000899243-22-023093 (filed Jun 17, 2022). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gouk WarrenCIK 0001865503Officer (Chief Administrative Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 9, 2022Common StockSSaleDisposed−10,000$7.32−$73,2006,265,330Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0000899243-22-022392 (filed Jun 14, 2022).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0000899243-22-022392
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 13, 2022Common StockSSaleDisposed−67,479$5.32−$358,988.286,275,330Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

This amendment has no footnotes.

Remarks

On June 14, 2022, the reporting person filed a Form 4 to report the sale of 10,000 shares of common stock of the issuer. On June 17, 2022, the reporting person subsequently filed an amendment to the Form 4 to report the sale of 5,000 shares of common stock of the issuer. Upon further review, the reporting person has determined that the number of shares sold as reported on the Form 4 filed on June 14, 2022 was correctly reported. As a result, the reporting person is filing this amendment to reflect the original number of shares sold.

Read the full filing on SEC EDGAR (opens in a new tab)